Delivery Order SPE2DB24D2106-SPE2DB25FAWCV
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $242,935.80 on August 14, 2025, by the Defense Logistics Agency's Medical Supply Chain division. The delivery order, issued under a firm fixed-price contract structure with an ultimate completion date of August 19, 2025, does not carry a set-aside designation. This award represents a single delivery order issuance against DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $18,488.12 on August 12, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, which is scheduled for completion by August 13, 2025, represents a task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $499.999 billion through November...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award valued at $4,169.59 from the Defense Logistics Agency's Medical Supply Chain division on August 4, 2025. This firm fixed-price delivery order, which carries an ultimate completion date of August 5, 2025, represents a task order issued under the company's larger single-award Indefinite Delivery Contract with the DLA valued at $499.999 billion and...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, received a firm fixed-price delivery order valued at $6,028.88 from the Defense Logistics Agency's Medical Supply Chain division on August 25, 2025. This delivery order, which will be completed by August 26, 2025, represents a task order issued under the company's larger Indefinite Delivery Contract with the DLA valued at $499.999 billion and valid through November 2026....
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $10,661.78 on August 13, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, with an ultimate completion date of September 18, 2025, represents a task order issued under the company's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $38k firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain division on August 11, 2025. This delivery order, with an ultimate completion date of August 19, 2025, represents a task order issued under the company's larger Indefinite Delivery Contract with the DLA valued at $500 million and extending through November 2026. The award...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $10,818.64 by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a direct purchase of pharmaceutical products for defense healthcare operations. The award carries no set-aside designation, allowing the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $10,776.12 on July 28, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, represents a task order issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program. The contract carries...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,682.34 by the Defense Logistics Agency (DLA) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed-price delivery order, issued under contract number 4569053648, was awarded without a set-aside designation and represents pharmaceutical supplies to be delivered to federal healthcare facilities. The award falls...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $7,762.20 by the Defense Logistics Agency's Medical Supply Chain division on August 21, 2025. This delivery order represents a task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA, a single-award vehicle valued at $499,999,999 and effective through November 2026. The contract...
- SPE2DB24D2106Indefinite Delivery Contract
- SPE2DB24D2106-SPE2DB25FAWCVDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,950.22 by the Defense Logistics Agency (DLA) on August 22, 2025. The delivery order, issued under DLA's larger Indefinite Delivery Contract (SPE2DB program) valued at $499.999 billion and valid through November 2026, calls for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in unit dose packaging (30 count). Performance will be completed by August 25, 2025, with the product delivered to Conshohocken, Pennsylvania. This award was made without a set-aside designation, demonstrating the vendor's competitive position in the federal pharmaceutical market. The delivery order represents a routine pharmaceutical supply transaction within DMS Pharmaceutical Group's established role as a critical supplier to Department of Defense healthcare facilities worldwide. The SPE2DB vehicle under which this order was issued enables the DLA to procure a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, biologics, and medical consumables, to support military health system requirements. DMS Pharmaceutical Group's consistent success in securing delivery orders through this contract vehicle underscores its reliable operational capacity and established vendor relationships within the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 8/22/25 |